You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Drugs Containing Excipient (Inactive Ingredient) POLYOXYL 40 CASTOR OIL


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing POLYOXYL 40 CASTOR OIL excipient, and estimated key patent expiration / generic entry dates

POLYOXYL 40 CASTOR OIL Market Analysis and Financial Projection Experimental

Polyoxyl 40 Hydrogenated Castor Oil: Market Dynamics and Financial Trajectory

Market Overview

Polyoxyl 40 Hydrogenated Castor Oil, also known as PEG-40 Hydrogenated Castor Oil, is a non-ionic surfactant and emulsifier derived from castor oil. This pharmaceutical excipient has seen significant growth in recent years, driven by its versatile applications in various industries.

Market Size and Growth

The global PEG-40 Hydrogenated Castor Oil market has demonstrated robust growth, reaching a value of US$ 60.1 million in 2022. It is projected to grow to US$ 112.9 million by 2030, with a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast period of 2023-2030[1][2].

Key Applications

Cosmetic and Personal Care Products

The cosmetic and personal care sector is the largest consumer of PEG-40 Hydrogenated Castor Oil. This excipient is widely used as an emulsifier, surfactant, and solubilizing agent in various cosmetic and personal care products. Its excellent moisturizing properties and ability to solubilize oils and fragrances make it a preferred ingredient in skincare and haircare products[1][2].

Pharmaceutical Formulations

In pharmaceuticals, PEG-40 Hydrogenated Castor Oil is used in liquid oral, topical, and parenteral formulations. It functions as an emulsifying agent, solubilizing agent, and wetting agent, particularly for lipidic and poorly soluble drugs, including fat-soluble vitamins A, D, E, and K. It is also utilized in veterinary pharmaceuticals to emulsify fish oils and other fats[4].

Regional Dynamics

Asia-Pacific Dominance

The Asia-Pacific region holds the largest share in the global PEG-40 Hydrogenated Castor Oil market. This dominance is attributed to the high production of castor beans in this region. For instance, according to a report by Professor Jayashankar Telangana State Agricultural University, the area under castor cultivation was 1.484 lakh ha, with a production rate of 17.74 lakh tones during 2021-22. This high production rate of castor beans supports the growth of the PEG-40 Hydrogenated Castor Oil market in the region[1].

Key Players and Market Developments

The market is characterized by the presence of several key players, including Croda International Plc, Matangi Industries, SpecialChem S.A, Kao Corporation, BASF Corporation, and others. These companies are continuously innovating and expanding their product portfolios. For example, Inolex released LexSolv Essential, a 100% natural solubilizer that includes PEG-40 hydrogenated castor oil, in September 2023[1][2].

Market Drivers

Increasing Demand in Cosmetics

The increasing demand for PEG-40 Hydrogenated Castor Oil in cosmetic and personal care products is a significant driver of market growth. The ingredient's ability to enhance the texture of formulations, solubilize oils and fragrances, and provide excellent moisturizing properties makes it highly sought after in the industry[1][2].

Sustainable and Innovative Formulations

The market is also driven by the trend towards sustainable and innovative formulations. Companies are introducing new products that incorporate PEG-40 Hydrogenated Castor Oil to meet consumer demands for natural and effective ingredients. For instance, Casterra Ag Ltd.'s agreement to supply high-yield castor seeds for biofuel production supports the expanding sustainable energy market and indirectly benefits the PEG-40 Hydrogenated Castor Oil market[2].

Safety and Regulatory Compliance

PEG-40 Hydrogenated Castor Oil has been extensively studied for its safety in various applications. It has been found to be essentially non-toxic and non-irritant in acute and chronic toxicity tests. The excipient is approved for use in pharmaceutical formulations and has undergone rigorous testing for toxicokinetics, reproductive and developmental toxicity, genotoxicity, carcinogenicity, and other safety parameters[4].

Financial Trajectory

The financial trajectory of the PEG-40 Hydrogenated Castor Oil market is positive, with a projected growth rate of 8.2% CAGR from 2023 to 2030. The market value is expected to nearly double from US$ 60.1 million in 2022 to US$ 112.9 million by 2030. This growth is supported by increasing demand, innovative product launches, and expanding applications in cosmetics and pharmaceuticals[1][2].

Market Insights and Analysis

The global PEG-40 Hydrogenated Castor Oil market report includes a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. These analyses provide insights into the market's competitive landscape, emerging trends, and key strategies adopted by market players[2].

Conclusion

The PEG-40 Hydrogenated Castor Oil market is poised for significant growth driven by its versatile applications, increasing demand in cosmetics, and the trend towards sustainable formulations. With a strong financial trajectory and a CAGR of 8.2%, this market is expected to continue its upward trend, benefiting both manufacturers and consumers.

Key Takeaways

  • Market Growth: The global PEG-40 Hydrogenated Castor Oil market is expected to grow from US$ 60.1 million in 2022 to US$ 112.9 million by 2030.
  • CAGR: The market is growing at a CAGR of 8.2% during the forecast period of 2023-2030.
  • Key Applications: Cosmetics, personal care, and pharmaceutical formulations.
  • Regional Dominance: Asia-Pacific region due to high castor bean production.
  • Safety Compliance: Approved pharmaceutical excipient with extensive safety testing.

FAQs

What is PEG-40 Hydrogenated Castor Oil used for?

PEG-40 Hydrogenated Castor Oil is used as an emulsifier, surfactant, and solubilizing agent in cosmetic, personal care, and pharmaceutical products.

Which region dominates the PEG-40 Hydrogenated Castor Oil market?

The Asia-Pacific region dominates the market due to high castor bean production.

What is the projected CAGR of the PEG-40 Hydrogenated Castor Oil market?

The market is projected to grow at a CAGR of 8.2% from 2023 to 2030.

Who are the key players in the PEG-40 Hydrogenated Castor Oil market?

Key players include Croda International Plc, Matangi Industries, SpecialChem S.A, Kao Corporation, and BASF Corporation.

Is PEG-40 Hydrogenated Castor Oil safe for use?

Yes, it has been found to be essentially non-toxic and non-irritant in various safety tests and is approved for use in pharmaceutical formulations.

Sources

  1. DataM Intelligence, "PEG-40 Hydrogenated Castor Oil Market - 2023-2030", GII Research.
  2. OpenPR, "Peg-40 Hydrogenated Castor Oil Market Growth Surge: Key Players and Market Insights".
  3. Research and Markets, "Pharmaceutical Excipients Global Market Report 2024".
  4. Pharmacentral, "Polyoxyethylene Hydrogenated Castor Oil Derivatives".

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.